CLINICAL_TRIALS
withdrawal
· 2017-06-12
Clinical Trial Update: Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Summary
A Phase 1 trial evaluating autologous ROR1R-CAR-T cells for chronic lymphocytic leukemia has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 1 | Status: WITHDRAWN